Fluorescein-based sensors to purify human a-cells for functional and transcriptomic analyses

Abstract

Pancreatic a-cells secrete glucagon, an insulin counter-regulatory peptide hormone critical for the maintenance of glucose homeostasis. Investigation of the function of human a-cells remains a challenge due to the lack of cost-effective purification methods to isolate high-quality a-cells from islets. Here, we use the reaction-based probe diacetylated Zinpyr1 (DA-ZP1) to introduce a novel and simple method for enriching live a-cells from dissociated human islet cells with ~ 95% purity. The a-cells, confirmed by sorting and immunostaining for glucagon, were cultured up to 10 days to form a-pseudoislets. The a-pseudoislets could be maintained in culture without significant loss of viability, and responded to glucose challenge by secreting appropriate levels of glucagon. RNA-sequencing analyses (RNA-seq) revealed that expression levels of key a-cell identity genes were sustained in culture while some of the genes such as DLK1, GSN, SMIM24 were altered in a-pseudoislets in a time-dependent manner. In conclusion, we report a method to sort human primary a-cells with high purity that can be used for downstream analyses such as functional and transcriptional studies.

Data availability

RNA-seq data have been deposited under accession code GSE199412. Further information and requests for resources and reagents should be directed to the corresponding author.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Sevim Kahraman

    Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, United States
    Competing interests
    Sevim Kahraman, S.K. is an employee of Boehringer Ingelheim Pharmaceuticals, Inc..
  2. Kimitaka Shibue

    Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, United States
    Competing interests
    No competing interests declared.
  3. Dario F De Jesus

    Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, United States
    Competing interests
    No competing interests declared.
  4. Hyunki Kim

    Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, United States
    Competing interests
    No competing interests declared.
  5. Jiang Hu

    Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, United States
    Competing interests
    No competing interests declared.
  6. Debasish Manna

    Chemical Biology and Therapeutics Science Program, Broad Institute, Cambridge, United States
    Competing interests
    No competing interests declared.
  7. Bridget K Wagner

    Chemical Biology and Therapeutics Science Program, Broad Institute, Cambridge, United States
    Competing interests
    No competing interests declared.
  8. Amit Choudhary

    Chemical Biology and Therapeutics Science Program, Broad Institute, Cambridge, United States
    Competing interests
    No competing interests declared.
  9. Rohit N Kulkarni

    Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, United States
    For correspondence
    rohit.kulkarni@joslin.harvard.edu
    Competing interests
    Rohit N Kulkarni, is on the Scientific Advisory Board of Novo Nordisk, Biomea and Inversago Therapeutics..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5029-6119

Funding

National Institutes of Health (U01 DK123717)

  • Bridget K Wagner
  • Rohit N Kulkarni

National Institutes of Health (UC4 DK116255)

  • Bridget K Wagner
  • Amit Choudhary
  • Rohit N Kulkarni

National Institutes of Health (R01 067536)

  • Rohit N Kulkarni

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2023, Kahraman et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,327
    views
  • 259
    downloads
  • 0
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Sevim Kahraman
  2. Kimitaka Shibue
  3. Dario F De Jesus
  4. Hyunki Kim
  5. Jiang Hu
  6. Debasish Manna
  7. Bridget K Wagner
  8. Amit Choudhary
  9. Rohit N Kulkarni
(2023)
Fluorescein-based sensors to purify human a-cells for functional and transcriptomic analyses
eLife 12:e85056.
https://doi.org/10.7554/eLife.85056

Share this article

https://doi.org/10.7554/eLife.85056

Further reading

    1. Biochemistry and Chemical Biology
    2. Stem Cells and Regenerative Medicine
    Alejandro J Brenes, Eva Griesser ... Angus I Lamond
    Research Article

    Human induced pluripotent stem cells (hiPSCs) have great potential to be used as alternatives to embryonic stem cells (hESCs) in regenerative medicine and disease modelling. In this study, we characterise the proteomes of multiple hiPSC and hESC lines derived from independent donors and find that while they express a near-identical set of proteins, they show consistent quantitative differences in the abundance of a subset of proteins. hiPSCs have increased total protein content, while maintaining a comparable cell cycle profile to hESCs, with increased abundance of cytoplasmic and mitochondrial proteins required to sustain high growth rates, including nutrient transporters and metabolic proteins. Prominent changes detected in proteins involved in mitochondrial metabolism correlated with enhanced mitochondrial potential, shown using high-resolution respirometry. hiPSCs also produced higher levels of secreted proteins, including growth factors and proteins involved in the inhibition of the immune system. The data indicate that reprogramming of fibroblasts to hiPSCs produces important differences in cytoplasmic and mitochondrial proteins compared to hESCs, with consequences affecting growth and metabolism. This study improves our understanding of the molecular differences between hiPSCs and hESCs, with implications for potential risks and benefits for their use in future disease modelling and therapeutic applications.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Jie Luo, Jeff Ranish
    Tools and Resources

    Dynamic conformational and structural changes in proteins and protein complexes play a central and ubiquitous role in the regulation of protein function, yet it is very challenging to study these changes, especially for large protein complexes, under physiological conditions. Here, we introduce a novel isobaric crosslinker, Qlinker, for studying conformational and structural changes in proteins and protein complexes using quantitative crosslinking mass spectrometry. Qlinkers are small and simple, amine-reactive molecules with an optimal extended distance of ~10 Å, which use MS2 reporter ions for relative quantification of Qlinker-modified peptides derived from different samples. We synthesized the 2-plex Q2linker and showed that the Q2linker can provide quantitative crosslinking data that pinpoints key conformational and structural changes in biosensors, binary and ternary complexes composed of the general transcription factors TBP, TFIIA, and TFIIB, and RNA polymerase II complexes.